Dose: 2,330 mcg (2.33 mg) total blend daily, providing approximately 1.7 mg GHK-Cu, 0.33 mg TB-500, and 0.33 mg BPC-157 per injection
Consult qualified professionals for research protocol guidance
BPC-157 tackles this problem directly by: Stimulating neoangiogenesis within the tendon or ligament substance Activating tenocytes (tendon cells) to produce organized collagen Reducing fibrotic adhesion formation that limits range of motion Condition-by-Condition Clinical Applications Tendinopathies Chronic tendon conditionsAchilles, patellar, rotator cuff, lateral epicondyle (tennis elbow), medial epicondyle (golfers elbow)respond exceptionally well to BPC-157
Prioritizing protein, micronutrient-dense vegetables, and healthy fats over processed foods becomes critical
If your calculated dose falls below 5 units (0.05 mL), you either need a 0.3 mL syringe with finer markings or you should add more bacteriostatic water to reduce the concentration